References

Scientific, technical and regulatory references on SURINERTS® pharmaceutical inert cores and starter pellet solutions, including peer-reviewed publications, patent literature, pharmaceutical documentation and specialized industry sources

Medsafe New Zealand / Rubifen LA - 2026

Official New Zealand Data Sheet for Rubifen LA modified-release capsules. SURINERTS® Sugar Spheres are listed as an excipient in all strengths from 10 mg to 60 mg.

Download

IMA Active / Process Worldwide - 2025

Taste masking coating of multi particulate systems in a small footprint equipment. Technical study using 20–25 mesh Sugar Spheres supplied by IPS as pharmaceutical starter cores.

Link | Download

International Journal of Pharmaceutics - 2024

Cushion-coated pellets for tableting without external excipients. Study using SURINERTS® Sugar Spheres 20/25 mesh supplied by IPS as starter cores.

Download

Pharmaceutics - 2022

Review on Starter Pellets: Inert and Functional Cores.
Scientific review of pharmaceutical starter pellets, including SURINERTS® among commercially available sugar sphere solutions.

Link 1 | Link 2 | Download

NCF - 2017

Tecnologie a rilascio modificato: oltre i pellets. Technical article on IPS pharmaceutical pellet technologies, including Sugar Spheres and 100% Tartaric Acid Pellets.

Link | Download

Vifor International AG / Patent WO2026120150A1 - 2026

Prolonged-release dosage forms of ferroportin inhibitors. Patent literature listing SURINERTS® among commercially available sucrose starter cores for layered prolonged-release pellets.

Link

Pharmaceutical Compositions of Ketotifen / Patent WO2025215658A1 - 2025

Patent on delayed and extended-release multiparticulate formulations identifying SURINERTS® among commercially available inert starter spheres for drug layering.

Link

V.V. Zakusov Research Institute / Patent RU2663691C2 - 2018

Pharmaceutical patent identifying SURINERTS® Sugar Spheres by IPS, Italy, among commercially available water-soluble sucrose pellet cores for pharmaceutical formulations.

Link

Qingyuan Huaneng Pharmaceutical / Patent CN101496794B - 2013

Enteric long-acting coating core and drug dosage form. Patent formulation using SURINERTS® Sugar Spheres 25/30 as starter cores for drug layering and controlled-release coating.

Link

AOU Sassari

Official public healthcare documentation listing SURINERTS® Sugar Spheres pharmaceutical microgranules in different supply formats.

Link

CPHI Online / Silaris Ingredients LLP

International pharmaceutical industry listing by Silaris Ingredients LLP referring to IPS Srl as its principal for Tartaric Acid Pellets and reporting a pre-assigned Drug Master File.

Link

Ron Pharm Group / IPS

International pharmaceutical distribution reference presenting SURINERTS® Sugar Spheres and Tartaric Acid Pellets manufactured by IPS, including their respective Drug Master File registrations.

Link

Farmalabor - Pharmaceutical Compounding

Professional pharmaceutical compounding listing including SURINERTS® Sugar Spheres pharmaceutical microgranules.

Link

Ask for information

If you need more information on the products, fill out the form below.

SURINERTS® is the pharmaceutical division of IPS , specialized in pharmaceutical-grade Sugar Spheres and Tartaric Acid Pellets. Our inert cores support drug layering, functional coating and multiparticulate oral dosage forms. Quality, regulatory support and reliable industrial supply for pharmaceutical manufacturers.

Contacts

Headquarters
Via Civesio, 6
20097 San Donato Milanese (MI) – Italy

Manufacturing plant
Via Tirso, 7/11
20098 San Giuliano Milanese (MI) – Italy

E- Mail
info@surinerts.it

Phone and Fax
+39 02.9880416

Scroll to Top